Takeda Pharmaceutical Company Limited TKPHF

TKPHF Company Overview

Takeda Pharmaceutical Company Limited is a Japan-based global biopharmaceutical company focused on the research, development, manufacture, and commercialization of prescription medicines and vaccines. The company operates primarily in the pharmaceutical and biotechnology industries, with core therapeutic focus areas that include gastroenterology and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines. Takeda generates revenue largely through patented specialty medicines, plasma-derived products, and global pharmaceutical sales across developed and emerging healthcare markets.

Takeda traces its origins to 1781 as a medicinal wholesaler in Osaka, Japan, and evolved into one of the world’s largest pharmaceutical companies through international expansion and acquisitions. A major transformation occurred with the 2019 acquisition of Shire plc, which significantly expanded Takeda’s rare disease portfolio and global footprint. The company positions itself as a research-driven biopharmaceutical organization with strong capabilities in specialty therapeutics, a broad international commercial infrastructure, and diversified revenue streams across multiple high-value therapeutic categories.